Quality management in today’s hospitals and health systems demands greater clinical collaboration to optimize care delivery within the parameters of value-based care. A true multi-disciplinary approach is characterized by each clinical function—whether pharmacy, infection prevention, nursing, physician or others—filling a critical role in optimal care delivery. For pharmacists, the mission is sharply focused on ensuring appropriate medication use, such as driving improved performance with antimicrobial stewardship to minimize the potential for healthcare-associated infections (HAIs). Pharmacists are leading efforts to improve patient safety related to medications, such as preventing adverse drug events (ADEs). Consider the following:
Additionally, publicly-reported HAIs represent a significant cause of patient morbidity and mortality and result in increased financial risk associated with elevated resource use, penalties incurred from regulatory and value-based performance programs as well as negative impact on reputation. Considering the role that antibiotic exposure plays in HAIs, it is incumbent upon pharmacists to effectively manage use of antimicrobials.
Resource-strapped pharmacy departments increasingly need a line of sight into the best infrastructures and workflows to improve performance in their domains of responsibility as it relates to quality performance. As such, the business case for investing in clinical surveillance technology is a relatively easy one to make.
Advanced solutions like Sentri7 deliver notable return on investment by providing critical IT support for programs aimed at optimizing medication management, infection prevention and antimicrobial stewardship. The reality is that most mid-tier EMRs lack surveillance capabilities, and larger systems require significant resources for building and maintaining evidence-based rules.
Through Sentri7, pharmacists can rely on continuous, real-time analysis and aggregation of patient data that pinpoints patients at risk. The system gathers critical information from EMRs and other disparate lab and clinical systems and leverages rules-based algorithms to flag potential medication, infection prevention and antimicrobial issues. Alerts are then immediately delivered to clinicians along with evidence-based clinical decision support to guide impactful clinical response.
And the results speak for themselves. Sentri7 delivers real results with a demonstrated impact on care quality, including:
- A 15% reduction in broad-spectrum antimicrobial use at a Texas hospital resulting in $1.6 million in one-year savings
- A $3.2 – $4.2 million savings from ADE reduction and workflow improvements at a North Carolina hospital
- A 364% cost reduction from ADE detection and prevention at a Pennsylvania health system
You can experience the same kind of results with Sentri7. Our customizable, out-of-the-box rules help you improve outcomes that impact performance for the CMS Value-based Purchasing Program, the Hospital-Acquired Conditions Reduction Program, and the CDC National Healthcare Safety Network (NHSN) reporting mandates.